Bicyclic Ureas as JAK2 Inhibitors for Treating Hematological Cancer.

ACS Med Chem Lett

Smith, Gambrell & Russell LLP, 1105 W. Peachtree Street NE, Suite 1000, Atlanta, Georgia 30309, United States.

Published: November 2024

Provided herein are novel bicyclic ureas as JAK2 inhibitors, pharmaceutical compositions, use of such compounds in treating hematological cancer, and processes for preparing such compounds.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11571020PMC
http://dx.doi.org/10.1021/acsmedchemlett.4c00496DOI Listing

Publication Analysis

Top Keywords

bicyclic ureas
8
ureas jak2
8
jak2 inhibitors
8
treating hematological
8
hematological cancer
8
inhibitors treating
4
cancer provided
4
provided novel
4
novel bicyclic
4
inhibitors pharmaceutical
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!